Drug Profile
BRL 32872
Alternative Names: BRL 32872A; BRL 3287ALatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Class III antiarrhythmics; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias
Most Recent Events
- 28 Sep 1998 Discontinued in Arrhythmias in United Kingdom (PO)
- 28 Sep 1998 Discontinued-Preclinical for Arrhythmias in France (Unknown route)
- 28 Sep 1998 Discontinued-Preclinical for Arrhythmias in USA (Unknown route)